PeptideDB

Lu AE58054 hydrochloride 467458-02-2

Lu AE58054 hydrochloride 467458-02-2

CAS No.: 467458-02-2

Lu AE58054 hydrochloride (also known as Idalopirdine hydrochloride) is potent and selective antagonist of the 5-HT(6) re
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Lu AE58054 hydrochloride (also known as Idalopirdine hydrochloride) is potent and selective antagonist of the 5-HT(6) receptor with Ki value of 0.83 nM. Lu AE58054 exhibited strong suppression of 5-HT-mediated activation but no agonist activity in a 5-HT(6) GTPgammaS efficacy assay. Lu AE58054 showed >50-fold selectivity for more than 70 targets studied in addition to medium affinity to adrenergic alpha(1A)- and alpha(1B)-adrenoreceptors. Lu AE58054 is being tested as an augmentation therapy in phase III clinical trials to treat cognitive deficits linked to schizophrenia and Alzheimer's disease.



Physicochemical Properties


Molecular Formula C20H20CLF5N2O
Molecular Weight 434.83
Exact Mass 434.118
Elemental Analysis C, 55.24; H, 4.64; Cl, 8.15; F, 21.85; N, 6.44; O, 3.68
CAS # 467458-02-2
Related CAS # Idalopirdine; 467459-31-0
PubChem CID 21071391
Appearance White to off-white solid powder
LogP 6.111
Hydrogen Bond Donor Count 3
Hydrogen Bond Acceptor Count 7
Rotatable Bond Count 9
Heavy Atom Count 29
Complexity 482
Defined Atom Stereocenter Count 0
SMILES

Cl[H].FC1C([H])=C([H])C2=C(C=1[H])N([H])C([H])=C2C([H])([H])C([H])([H])N([H])C([H])([H])C1C([H])=C([H])C([H])=C(C=1[H])OC([H])([H])C(C([H])(F)F)(F)F

InChi Key KXOQNPANAFXKTN-UHFFFAOYSA-N
InChi Code

InChI=1S/C20H19F5N2O.ClH/c21-15-4-5-17-14(11-27-18(17)9-15)6-7-26-10-13-2-1-3-16(8-13)28-12-20(24,25)19(22)23;/h1-5,8-9,11,19,26-27H,6-7,10,12H2;1H
Chemical Name

2-(6-fluoro-1H-indol-3-yl)-N-[[3-(2,2,3,3-tetrafluoropropoxy)phenyl]methyl]ethanamine;hydrochloride
Synonyms

Lu AE58054 Hydrochloride; Idalopirdine Hydrochloride; Iladopirdine HCl; Lu AE58054 HCl
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment, avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets 5-HT6 Receptor ( Ki = 0.83 nM )
ln Vitro

In vitro activity: In vivo binding of the 5-HT(6) antagonist radioligand [(3)H]Lu AE60157 was potently inhibited by oral administration of Lu AE58054, with an ED(50) of 2.7 mg/kg. The plasma EC(50) value of 20 ng/ml was found through steady-state modeling of an acute pharmacokinetic/5-HT(6)R occupancy time-course experiment.

ln Vivo
Idalopirdine (5 mg/kg intraperitoneally injected daily for 28 days) In overeating rat models, hydrochloride can lower body weight and food intake[1].
Idalopirdine (i.v., 1 or 2 mg/kg) While donepezil's effect on cortical gamma oscillations can be enhanced by hydrochloride in a dose-dependent manner during nPO electrical stimulation, rats' sleep-wake patterns remain unchanged[2].
Animal Protocol Male Wistar rats
5 mg/kg
intraperitoneal injection, daily, 28 days
References

[1]. Idalopirdine, a selective 5-HT6 receptor antagonist, reduces food intake and body weight in a model of excessive eating. Metab Brain Dis. 2018 Jun;33(3):733-740.

[2]. The 5-HT6 receptor antagonist idalopirdine potentiates the effects of donepezil on gamma oscillations in the frontal cortex of anesthetized and awake rats without affecting sleep-wake architecture. Neuropharmacology. 2017 Feb;113(Pt A):45-59.


Solubility Data


Solubility (In Vitro)
DMSO: ≥ 25 mg/mL (~57.5 mM)
Water: <1 mg/mL
Ethanol: N/A
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (5.75 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (5.75 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.5 mg/mL (5.75 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.2997 mL 11.4987 mL 22.9975 mL
5 mM 0.4599 mL 2.2997 mL 4.5995 mL
10 mM 0.2300 mL 1.1499 mL 2.2997 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.